{"url":"https://lda.gov/api/v1/filings/43d26c2e-d977-4f9c-b2a7-6ef9ef42bb92/","filing_uuid":"43d26c2e-d977-4f9c-b2a7-6ef9ef42bb92","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/43d26c2e-d977-4f9c-b2a7-6ef9ef42bb92/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Edward B. Stewart","dt_posted":"2026-04-17T17:38:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1331 Pennsylvania Avenue, NW","registrant_address_2":"Suite 400 South","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":401104254,"url":"https://lda.gov/api/v1/registrants/401104254/","house_registrant_id":43449,"name":"NOVEL STRATEGIES (FKA) PRISM GROUP","description":"A public affairs and government relations firm.","address_1":"1331 Pennsylvania Avenue, NW","address_2":"Suite 400 South","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"EDWARD STEWART","contact_telephone":"+1 202-683-4079","dt_updated":"2026-04-17T16:41:47.330027-04:00"},"client":{"id":209962,"url":"https://lda.gov/api/v1/clients/209962/","client_id":191,"name":"INCUBATE","general_description":"A coalition of venture capital organizations","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Ensuring Pathways to Innovative Cures (EPIC) Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148918,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"GUY","suffix":null,"suffix_display":null},"covered_position":"n/a","new":false},{"lobbyist":{"id":153490,"prefix":null,"prefix_display":null,"first_name":"BAYLEE","nickname":null,"middle_name":null,"last_name":"FINGERHUT","suffix":null,"suffix_display":null},"covered_position":"n/a","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}